LENZ Therapeutics
Signal active
Organization
Contact Information
Overview
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes. Its program is an aceclidine-based eye drop designed to restore the loss of near vision associated with presbyopia.
About
Industries
Health Care, Pharmaceutical, Medical, Therapeutics
Founded
2013
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
LENZ Therapeutics headquartered in United States, North America, operates in the Health Care, Pharmaceutical, Medical, Therapeutics sector. The company focuses on Health Care and has secured $17.4B in funding across 80 round(s). With a team of 11-50 employees, LENZ Therapeutics is actively contributing to advancements in Health Care. Their latest funding round, Venture Round - LENZ Therapeutics, raised $3.4M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
0
Lead Investors
0
Total Funding Amount
$217.4M
Details
2
LENZ Therapeutics has raised a total of $217.4M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 47.0M | ||
| 2023 | Early Stage Venture | 83.5M |
Investors
LENZ Therapeutics is funded by 18 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| RA Capital Management | - | FUNDING ROUND - RA Capital Management | 53.5M |
| RTW Investments | - | FUNDING ROUND - RTW Investments | 53.5M |
| LENZ Therapeutics | - | FUNDING ROUND - LENZ Therapeutics | 53.5M |
| Alpha Wave Global | - | FUNDING ROUND - Alpha Wave Global | 53.5M |
Recent Activity
There is no recent news or activity for this profile.